drugset / Trial / NCT02025361

Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy

NCT02025361

Phase 4 Completed 422 enrolled Bagcilar Training and Research Hospital
Non-randomizedFactorialOpen-labelDiagnostic

Summary

Transrectal ultrasound guided prostate biopsy (TRUS-Bx) is the gold standard method for prostat cancer diagnosis. Cancer detection rate is an important issue in TRUS-Bx. Effective biopsy protocol is necessary to enhance cancer detection rate during the procedure. Patient tolerance may improve the protocol effectiveness and quality. Adequate patient tolerance with optimal local anesthesia may enhance cancer detection rate in TRUS-Bx.

Timeline

Start
2009-02
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 % Rectal
Subject prilocaine Small molecule 2 % Other
Subject prilocaine Small molecule 5 ml Other